Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Covalon leverages its patented medical technology platforms and expertise in two ways: i we develop products that we sell under Covalon s name and ii we develop and commercialize medical products for other medical companies under development and license contracts.
Quote | Covalon Techs Ltd (OTCMKTS:CVALF)
Last: | $1.51 |
---|---|
Change Percent: | 0.0% |
Open: | $1.51 |
Close: | $1.51 |
High: | $1.51 |
Low: | $1.51 |
Volume: | 2,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Covalon Techs Ltd (OTCMKTS:CVALF)
2024-05-29 12:50:24 ET Covalon Technologies Ltd. (CVALF) Q2 2024 Results Conference Call May 29, 2024 8:15 AM ET Company Participants Brent Ashton - CEO Katie Martinovich - Interim CFO Saleha Assadzada - Executive Assistant-CEO Conference Call Participants ...
2024-05-29 07:42:42 ET More on Covalon Technologies Financial information for Covalon Technologies Read the full article on Seeking Alpha For further details see: Covalon Technologies GAAP EPS of $0.06, revenue of $8.41M
Message Board Posts | Covalon Techs Ltd (OTCMKTS:CVALF)
Subject | By | Source | When |
---|---|---|---|
CVALF buy 3.4469 | stocktrademan | investorshub | 12/03/2017 4:25:32 PM |
Stock_Tracker: Latest Covalon Tech Ltd (CVALF) Headlines The Global Biomaterials Market with Forecas | Stock_Tracker | investorshangout | 03/09/2014 5:00:56 PM |
chartguy89: CVALF 1.341 Stock Charts $CVALF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 10:31:26 PM |
chartguy89: CVALF Stock Charts Last: +0.0087 Tuesday, February 25, 2014 at 4:14:31 AM $CVALF | chartguy89 | investorshangout | 02/25/2014 9:14:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Recent changes and effective execution pave the way for strong Q2 results Q2 EBITDA of $1.7 million, Adjusted EBITDA of $2.5 million, and EPS of $0.06 Q2 year-on-year Revenue growth of 16%, focus area of US Product segment grew 54% Q2 Gross Margin increased to 63%, the h...
Faraday Future Intelligent Electric Inc. (FFIE) is expected to report for Q1 2024 D-Market Electronic Services & Trading (HEPS) is expected to report for Q1 2024 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2024 Check-Cap Ltd. (CHEK) is expected to report $-0.17 for ...
Covalon Technologies Ltd. (CVALF) is expected to report for Q2 2024